Schedule of Private Placement Warrants (Details) - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Warrant | ||
| Number of shares, beginning balance | 22,392,004 | 22,392,004 |
| Weighted average exercise price, beginning balance | $ 0.1963 | $ 0.1963 |
| Issued | ||
| Exercised | ||
| Expired or cancelled | ||
| Number of shares, ending balance | 22,392,004 | 22,392,004 |
| Weighted average exercise price, ending balance | $ 0.1963 | $ 0.1963 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|